← Eichor
Study identifier: NCT06865651 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

Condition: Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 2
Planned participants44
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The purpose of this study is to explore the effect and Mechanism of Action (MoA) of remibrutinib (LOU064) vs. placebo on clinical outcomes in participants with Chronic Urticaria (CU), including both Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CINDU).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  1-888-669-6682  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  +41613241111

Always discuss trial participation with your own doctor first.

Locations (17)

Ziaderm Research LLCNorth Miami Beach, Florida, United StatesRecruiting
Endeavor HealthGlenview, Illinois, United StatesRecruiting
Novartis Investigative SiteGrenoble, FranceRecruiting
Novartis Investigative SiteMontpellier, FranceRecruiting
Novartis Investigative SiteParis, FranceRecruiting
Novartis Investigative SitePierre-Bénite, FranceRecruiting
Novartis Investigative SiteDresden, Saxony, GermanyRecruiting
Novartis Investigative SiteBerlin, GermanyRecruiting
Novartis Investigative SiteMainz, GermanyWithdrawn
Novartis Investigative SiteTübingen, GermanyRecruiting
Novartis Investigative SitePoznan, PolandRecruiting
Novartis Investigative SiteRzeszów, PolandWithdrawn

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06865651